Lataa...
Treatment of human cells with 5-aza-dC induces formation of PARP1-DNA covalent adducts at genomic regions targeted by DNMT1
The nucleoside analog 5-aza-2’-deoxycytidine (5-aza-dC) is used to treat some hematopoietic malignancies. The mechanism of cell killing depends upon DNMT1, but is otherwise not clearly defined. Here we show that PARP1 forms covalent DNA adducts in human lymphoblast or fibroblasts treated with 5-aza-...
Tallennettuna:
| Julkaisussa: | DNA Repair (Amst) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669653/ https://ncbi.nlm.nih.gov/pubmed/33039802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dnarep.2020.102977 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|